DJIA 17,811.28 -3.66 -0.02%
NASDAQ 4,765.26 7.01 0.15%
S&P 500 2,067.39 0.36 0.02%
market minute promo


3.09 0.03 (0.98%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRS $3.09 0.98%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.05
Previous Close $3.06
Daily Range $2.98 - $3.10
52-Week Range $2.54 - $6.11
Market Cap $244.3M
P/E Ratio -1.10
Dividend (Yield) $0.00 (0.0%)
Volume 10,105
Average Daily Volume 159,555
Current FY EPS -$1.23






Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Website:

News & Commentary Rss Feed

Should You Buy Solazyme After Its Big Drop?

Solazyme stock went cliff-diving last week. Is it time to buy?

2 Airlines Are Already Using Biofuels, So Why Aren't We All Flying Green?

Biofuels aren't just for your cars anymore. With major airlines taking a serious look, will you be on a bio-flight soon?

Solazyme Pivots Commercialization Strategy, But Does Amyris Do It Better?

Solazyme realized that it needs to sell high value products to survive, but Amyris realized that over 12 months ago. What can investors learn from execution at Amyris, and how does it translate to the new strategy at Solazyme?

Amyris' (AMRS) CEO John Melo on Q3 2014 Results - Earnings Call Transcript

Amyris (AMRS) Q3 2014 Results - Earnings Call Webcast

5 Best Stocks to Buy in Renewable Energy

Clean and sustainable technologies are no longer a mere pipe dream. What are the best stocks to buy in renewable energy? Here are five, ranging from solar power to biodiesel, electric cars to engineered yeast.

3 Reasons Solazyme Inc. Stock Will Rise From All-Time Lows

Don't get too down in the dumps! It's important to be realistic, but Solazyme stock should rise from these levels.

3 Stocks Improving Performance Of The Chemicals Industry

3 Chemicals Stocks Moving The Industry Upward

Can Amyris (AMRS) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

See More AMRS News...

AMRS's Top Competitors

AMRS $3.09 (0.98%)
Current stock: AMRS
RTK $1.38 (0.00%)
Current stock: RTK
FCEL $1.78 (-0.56%)
Current stock: FCEL
SZYM $2.67 (1.91%)
Current stock: SZYM